›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:UltraSEEK® Lung Panel
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Agena BioType:
Laboratory Developed Test
Related tests:
The UltraSEEK Lung Panel enables study of disease progression and resistance in non-small cell lung cancer. Detects over 70 clinically relevant variants across BRAF, EGFR, ERBB2, KRAS and PIK3CA. Identifies variants at as low as 0.1% variant allele frequency. Uses as little as 10 ng of cfDNA. 1 hour of hands-on time and 8 hours of total time.
Cancer:
Non Small Cell Lung Cancer
Gene:
BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), HER-2 (Human epidermal growth factor receptor 2), KRAS (KRAS proto-oncogene GTPase), PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha)
BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), HER-2 (Human epidermal growth factor receptor 2), KRAS (KRAS proto-oncogene GTPase), PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha)
